← All trials
NCT05445089
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2020
- Primary completion
- Nov 1, 2020
- Completion date
- Dec 15, 2020
- First posted
- Jul 6, 2022
- Last posted
- Jul 8, 2022
- Enrollment
- 600
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Instituto Venezolano de Investigaciones CientificasLead sponsor
- Instituto Venezolano de Investigaciones CientificasReponsible party - principal investigator
- Biosynthesis MedicalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.